Dosimetry of in situ activated dysprosium microspheres.
This paper presents the results of a study aimed at investigating the dosimetry of stable dysprosium microspheres activated, in situ, by a linac generated photon beam. In phantom measurements of the neutron flux within an 18 MV photon beam were performed using CR-39 detectors and gold activation. The results were used in conjunction with a Monte Carlo computer simulation to investigate the dose distribution resulting from the activation of dysprosium (Dy) microspheres using an 18 MV photon beam. Different depths, lesion volumes and volume concentrations of microspheres are investigated. The linac lower collimator jaws are assumed completely closed to shield the tumour volume from the photon dose. Using a single AP field with 0 x 0 cm2 field size (closed jaws), a photon dose rate of 600 MU min(-1) and 80 cm SSD for 10 min, an average dose exceeding 1 Gy can be delivered to spherical lesions of 0.5 cm and higher diameter. The variation of the average dose with the size of the lesion reaches saturation for tumour volumes exceeding 1 cm in diameter. This report shows that the photon beam of a high-energy linac can be used to activate Dy microspheres in situ and, as a result, deliver a significant dose of beta radiation. Non-radioactive Dy microspheres do not have the toxicity and imaging problems associated with commercially available yttrium-90 based products.
Adnani
N
N
NTI Medical Inc., Suite 1150, Manulife Place, 10180-101 Street, Edmonton, Alberta T5J 3S4, Canada.
D004307:Dose-Response Relationship, Radiation; D005214:Fast Neutrons; D006358:Hot Temperature; D008863:Microspheres; D015233:Models, Statistical; D009010:Monte Carlo Method; D009502:Neutrons; D010315:Particle Accelerators; D019047:Phantoms, Imaging; D017785:Photons; D011829:Radiation Dosage; D011874:Radiometry / Q000379:methods*; D011880:Radiotherapy Planning, Computer-Assisted; D013997:Time Factors; D015021:Yttrium Radioisotopes
D015021:Yttrium Radioisotopes